UTABON

This brand name is authorized in Spain, Malta

Active ingredients

The drug UTABON contains one active pharmaceutical ingredient (API):

1 Oxymetazoline UNII K89MJ0S5VY - OXYMETAZOLINE HYDROCHLORIDE

Oximetazoline is an imidazoline derivative. It exhibits sympathomimetic activity and specifically stimulates the α-adrenergic receptors of the sympathetic system. When administered topically to the nose it causes vasoconstriction of the expansed arterioles of the mucosal nose and a concurrent reduction in blood flow. It also reduces the hypersecretion of the nasal mucosa, ultimately contributing to the decongestion of the nasal mucosa. Read about Oxymetazoline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
UTABON ADULTS Nasal spray, solution	Medicines Authority (MT)	MPI, EU: SmPC
UTABON PEDIATRIC Nasal drops, solution	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AA05	Oxymetazoline	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AA Sympathomimetics, plain
Discover more medicines within R01AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 46065, 46066, 67307
Country: MT	Medicines Authority	Identifier(s): MA131/00501, MA131/00502